HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sheng-Hua Li Selected Research

Neoplasms (Cancer)

6/2022Clinical significance and potential regulatory mechanism of overexpression of pituitary tumor-transforming gene transcription factor in bladder cancer.
6/2022Metadherin Promotes the Development of Bladder Cancer by Enhancing Cell Division.
5/2022Decreased expression of transcription factor Homeobox A11 and its potential target genes in bladder cancer.
1/2019Identifying TF-miRNA-mRNA regulatory modules in nitidine chloride treated HCC xenograft of nude mice.
1/2019MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays.
12/2018Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics.
7/2018Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
5/2018Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
1/2018Clinical significance and effect of MTDH/AEG-1 in bladder urothelial cancer: a study based on immunohistochemistry, RNA-seq, and in vitro verification.
7/2017A nanobody targeting carcinoembryonic antigen as a promising molecular probe for non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sheng-Hua Li Research Topics

Disease

10Neoplasms (Cancer)
06/2022 - 07/2017
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 05/2018
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2022 - 05/2022
2Wounds and Injuries (Trauma)
01/2021 - 05/2008
2Osteonecrosis (Kienbock's Disease)
01/2021 - 06/2012
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2019 - 09/2014
2Carcinoma (Carcinomatosis)
01/2018 - 09/2014
2Ischemic Stroke
07/2017 - 01/2015
2Brain Ischemia (Cerebral Ischemia)
07/2017 - 06/2015
1Pituitary Neoplasms (Pituitary Adenoma)
06/2022
1Spinal Stenosis (Stenosis, Spinal)
01/2021
1Necrosis
01/2021
1Inflammation (Inflammations)
05/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2020
1Carcinogenesis
01/2020
1Pain (Aches)
07/2019
1Squamous Cell Carcinoma of Head and Neck
05/2019
1Lymphatic Metastasis
12/2018
1Residual Neoplasm
12/2018
1Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
05/2018
1Knee Osteoarthritis
02/2018
1Lung Neoplasms (Lung Cancer)
07/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2017
1Ischemia
06/2015
1Infarction (Infarctions)
06/2015
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2015
1Atherosclerosis
01/2015
1Cardiovascular Diseases (Cardiovascular Disease)
01/2015
1Pneumoperitoneum
01/2014
1Hypoxia (Hypoxemia)
09/2008
1Hyperlactatemia
09/2008
1Intervertebral Disc Displacement (Herniated Disc)
05/2008

Drug/Important Bio-Agent (IBA)

6MicroRNAs (MicroRNA)IBA
05/2019 - 01/2015
3Biological ProductsIBA
06/2022 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2021 - 07/2017
3Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2015
3Messenger RNA (mRNA)IBA
01/2019 - 06/2015
2Transcription Factors (Transcription Factor)IBA
06/2022 - 05/2022
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2019 - 07/2018
2nitidineIBA
01/2019 - 01/2019
2Oxygen (Dioxygen)IBA
07/2017 - 09/2008
1Nonprescription Drugs (Patent Medicines)IBA
05/2020
1Analgesics (Analgesic Drugs)IBA
05/2020
1tougu xiaotongIBA
07/2019
1Long Noncoding RNAIBA
01/2019
1Prostate-Specific Antigen (Semenogelase)IBA
12/2018
1Transforming Growth Factor beta (TGF-beta)IBA
05/2018
1Therapeutic UsesIBA
02/2018
1youguiIBA
02/2018
1Propidium (Propidium Iodide)IBA
01/2018
1Caspase 3 (Caspase-3)IBA
01/2018
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
07/2017
1Carcinoembryonic AntigenIBA
07/2017
1Molecular Probes (Molecular Probe)IBA
07/2017
1Untranslated RNA (Noncoding RNA)IBA
06/2015
1rat MIRN676 microRNAIBA
06/2015
1Neuroprotective AgentsIBA
06/2015
1Fluorescein-5-isothiocyanate (FITC)IBA
09/2014
1Ethanol (Ethyl Alcohol)IBA
09/2014
1FITC-annexin A5IBA
09/2014
1SuspensionsIBA
01/2014

Therapy/Procedure

2Decompression
01/2021 - 05/2008
1Tibetan Traditional Medicine (Traditional Tibetan Medicine)
07/2019
1Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2018
1Therapeutics
07/2017
1Conservative Treatment
06/2012
1Diskectomy (Discectomy)
05/2008